Vanquish Oncology, Inc.
2 clinical trials · Sponsor
◉ Watch Vanquish Oncology, Inc.
| Record | Firm | Date |
|---|---|---|
| Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 2 (NCT03332355) | Vanquish Oncology, Inc. | 2017-10-01 |
| Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 1 (NCT02355535) | Vanquish Oncology, Inc. | 2015-02-01 |
Track Vanquish Oncology, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.